TY  - JOUR
AU  - Salcedo, Magdalena
AU  - Prieto, Martín
AU  - Castells, Lluís
AU  - Pascasio, Juan Manuel
AU  - Montero Alvarez, Jose Luis
AU  - Fernández, Inmaculada
AU  - Sánchez-Antolín, Gloria
AU  - González-Diéguez, Luisa
AU  - García-Gonzalez, Miguel
AU  - Otero, Alejandra
AU  - Lorente, Sara
AU  - Espinosa, Maria Dolores
AU  - Testillano, Milagros
AU  - González, Antonio
AU  - Castellote, Jose
AU  - Casafont, Fernando
AU  - Londoño, Maria-Carlota
AU  - Pons, Jose Antonio
AU  - Molina Pérez, Esther
AU  - Cuervas-Mons, Valentín
AU  - Pascual, Sonia
AU  - Herrero, Jose Ignacio
AU  - Narváez, Isidoro
AU  - Vinaixa, Carmen
AU  - Llaneras, Jordi
AU  - Sousa, Jose Manuel
AU  - Bañares, Rafael
PY  - 2017
DO  - 10.1111/tri.12999
UR  - http://hdl.handle.net/10668/11296
T2  - Transplant international : official journal of the European Society for Organ Transplantation
AB  - Direct-acting antiviral agents (DAA) combining daclatasvir (DCV) have reported good outcomes in the recurrence of hepatitis C virus (HCV) infection after liver transplant (LT). However, its effect on the severe recurrence and the risk of death remains...
LA  - en
KW  - Model for End-Stage Liver Disease
KW  - daclatasvir
KW  - efficacy and safety
KW  - recurrence of HCV
KW  - survival prognostic model
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antiviral Agents
KW  - Carbamates
KW  - Female
KW  - Hepatitis C
KW  - Humans
KW  - Imidazoles
KW  - Immunosuppression Therapy
KW  - Liver Transplantation
KW  - Male
KW  - Middle Aged
KW  - Postoperative Complications
KW  - Pyrrolidines
KW  - Recurrence
KW  - Retrospective Studies
KW  - Spain
KW  - Sustained Virologic Response
KW  - Valine
TI  - Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study.
TY  - research article
VL  - 30
ER  -